Red Door Wealth Management, LLC Oncolytics Biotech Inc Transaction History

Red Door Wealth Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Oct 14, 2021	SELL	$1.93 - $2.77 $1,930 - $2,770	-1,000 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$2.6 - $4.64 $2,600 - $4,640	1,000 New	1,000 $2,000

1.18M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $49.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Red Door Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Red Door Wealth Management, LLC with notifications on news.